Journal of Experimental Medicine, Vol 174, 649-655, Copyright © 1991 by Rockefeller University Press

ARTICLES

Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils

CE Ooi, J Weiss, ME Doerfler and P Elsbach
Department of Microbiology, New York University School of Medicine, New York 10016.

The bactericidal/permeability-increasing protein (BPI) of polymorphonuclear leukocytes (PMN) is a potent cytotoxin, specific for Gram-negative bacteria, that also inhibits endotoxin activity by neutralizing isolated bacterial lipopolysaccharides (LPS). We have previously shown that an isolated 25 kD N-terminal fragment of human BPI carries all the antibacterial activities of the parent 55-60 kD molecule. In this study we have compared the LPS-neutralizing activities of human holo-BPI, the N-terminal fragment and a 30 kD C- terminal fragment that we have now isolated. We show that the N- terminal fragment also has LPS-neutralizing activity as detected by inhibition (up to 95%) of (a) activation by LPS of procoagulant proteases in Limulus amebocyte lysates, (b) LPS "priming" of PMN, and (c) LPS-mediated production of tumor necrosis factor in whole human blood. Holo-BPI and the 25 kD fragment have similar neutralizing potency (in nanomolar range) in all assays toward "smooth" LPS from Escherichia coli O111:B4 and O55:B5 (possessing long chain polysaccharide or O-antigen), and "deep rough" LPS from Salmonella minnesota Re595 mutant (possessing no O-antigen). The C-terminal fragment of BPI is devoid of antibacterial activity when tested against BPI-sensitive E. coli J5, but does have endotoxin-neutralizing activity. This activity is weak relative to holo-BPI and the 25 kD N- terminal fragment in the Limulus and PMN-priming assay, but is comparable for inhibition of TNF production in whole blood. We conclude that the principal determinants for LPS recognition and neutralization, like those for antibacterial action, reside in the N-terminal half of the BPI molecule, but that sites within the C-terminal half can also contribute to BPI-LPS interaction once LPS is detached from the bacterial envelope.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Harder, J., Glaser, R., Schroder, J.-M. (2007). Review: Human antimicrobial proteins effectors of innate immunity. Innate Immunity 13: 317-338 [Abstract]  
• Chen, J., Li, C., Guan, Y., Kong, Q., Li, C., Guo, X., Chen, Q., Jing, X., Lv, Z., An, Y. (2007). Protection of Mice from Lethal Escherichia coli Infection by Chimeric Human Bactericidal/Permeability-Increasing Protein and Immunoglobulin G1 Fc Gene Delivery. Antimicrob. Agents Chemother. 51: 724-731 [Abstract] [Full Text]  
• Gutsmann, T., Hagge, S. O., David, A., Roes, S., Bohling, A., Hammer, M. U., Seydel, U. (2005). Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides. Innate Immunity 11: 167-173 [Abstract]  
• Khovidhunkit, W., Hachem, J. P., Medzihradszky, K. F., Duchateau, P. N., Shigenaga, J. K., Moser, A. H., Movsesyan, I., Naya-Vigne, J., Kane, J. P., Feingold, K. R., Grunfeld, C. (2005). Parotid secretory protein is an HDL-associated protein with anticandidal activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R1306-R1315 [Abstract] [Full Text]  
• Levy, O. (2004). Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J. Leukoc. Biol. 76: 909-925 [Abstract] [Full Text]  
• Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
• Wiese, A., Gutsmann, T., Seydel, U. (2003). Review: Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. Innate Immunity 9: 67-84 [Abstract]  
• Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., Hancock, R. E. W. (2002). The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses. J. Immunol. 169: 3883-3891 [Abstract] [Full Text]  
• Thomas, J. A., Tsen, M. F., White, D. J., Horton, J. W. (2002). TLR4 inactivation and rBPI21 block burn-induced myocardial contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 283: H1645-H1655 [Abstract] [Full Text]  
• Inagawa, H., Honda, T., Kohchi, C., Nishizawa, T., Yoshiura, Y., Nakanishi, T., Yokomizo, Y., Soma, G.-I. (2002). Cloning and Characterization of the Homolog of Mammalian Lipopolysaccharide-Binding Protein and Bactericidal Permeability-Increasing Protein in Rainbow Trout Oncorhynchus mykiss. J. Immunol. 168: 5638-5644 [Abstract] [Full Text]  
• Rauniyar, R. K., Suzuma, K., King, A. L., Aiello, L. P., King, G. L. (2002). Differential Effects of Bactericidal/Permeability-Increasing Protein (BPI) Analogues on Retinal Neovascularization and Retinal Pericyte Growth. IOVS 43: 503-509 [Abstract] [Full Text]  
• Hiki, N., Mimura, Y., Ogawa, T., Kojima, J., Hatao, F., Kaminishi, M. (2001). Pathophysiological relevance of the CD14 receptor in surgical patients: biological activity of endotoxin is regulated by the CD14 receptor. Innate Immunity 7: 461-466 [Abstract]  
• Schultz, H., Weiss, J., Carroll, S. F., Gross, W. L. (2001). The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies. J. Leukoc. Biol. 69: 505-512 [Abstract] [Full Text]  
• Bülow, E., Gullberg, U., Olsson, I. (2000). Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein. J. Leukoc. Biol. 68: 669-678 [Abstract] [Full Text]  
• Scott, M. G., Rosenberger, C. M., Gold, M. R., Finlay, B. B., Hancock, R. E. W. (2000). An {alpha}-Helical Cationic Antimicrobial Peptide Selectively Modulates Macrophage Responses to Lipopolysaccharide and Directly Alters Macrophage Gene Expression. J. Immunol. 165: 3358-3365 [Abstract] [Full Text]  
• Levy, O., Sisson, R. B., Kenyon, J., Eichenwald, E., Macone, A. B., Goldmann, D. (2000). Enhancement of Neonatal Innate Defense: Effects of Adding an N-Terminal Recombinant Fragment of Bactericidal/Permeability-Increasing Protein on Growth and Tumor Necrosis Factor-Inducing Activity of Gram-Negative Bacteria Tested in Neonatal Cord Blood Ex Vivo. Infect. Immun. 68: 5120-5125 [Abstract] [Full Text]  
• David, S. A., Awasthi, S. K., Balaram, P. (2000). The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides. Innate Immunity 6: 249-256 [Abstract]  
• Dankesreiter, S., Hoess, A., Schneider-Mergener, J., Wagner, H., Miethke, T. (2000). Synthetic Endotoxin-Binding Peptides Block Endotoxin- Triggered TNF-{alpha} Production by Macrophages In Vitro and In Vivo and Prevent Endotoxin-Mediated Toxic Shock. J. Immunol. 164: 4804-4811 [Abstract] [Full Text]  
• Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., Gold, M. R. (2000). Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein. J. Immunol. 164: 549-553 [Abstract] [Full Text]  
• Hiki, N., Berger, D., Dentener, M. A., Mimura, Y., Buurman, W. A., Prigl, C., Seidelmann, M., Tsuji, E., Kaminishi, M., Beger, H. G. (1999). Changes in Endotoxin-Binding Proteins during Major Elective Surgery: Important Role for Soluble CD14 in Regulation of Biological Activity of Systemic Endotoxin. CVI 6: 844-850 [Abstract] [Full Text]  
• Huuskonen, J., Wohlfahrt, G., Jauhiainen, M., Ehnholm, C., Teleman, O., Olkkonen, V. M. (1999). Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J. Lipid Res. 40: 1123-1130 [Abstract] [Full Text]  
• Medvedev, A. E., Flo, T., Ingalls, R. R., Golenbock, D. T., Teti, G., Vogel, S. N., Espevik, T. (1998). Involvement of CD14 and Complement Receptors CR3 and CR4 in Nuclear Factor-{kappa}B Activation and TNF Production Induced by Lipopolysaccharide and Group B Streptococcal Cell Walls. J. Immunol. 160: 4535-4542 [Abstract] [Full Text]  
• Iovine, N. M., Elsbach, P., Weiss, J. (1997). An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains. Proc. Natl. Acad. Sci. USA 94: 10973-10978 [Abstract] [Full Text]  
• Tobias, P. S., Soldau, K., Iovine, N. M., Elsbach, P., Weiss, J. (1997). Lipopolysaccharide (LPS)-binding Proteins BPI and LBP Form Different Types of Complexes with LPS. J. Biol. Chem. 272: 18682-18685 [Abstract] [Full Text]  
• Beamer, L. J., Carroll, S. F., Eisenberg, D. (1997). Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution. Science 276: 1861-1864 [Abstract] [Full Text]  
• Liang, A.H., Ohno, N., Yadomae, T. (1997). Inhibition of antibiotic-induced lysis and lipopolysaccharide release from Escherichia coli 0111 :B4 by egg white lysozyme. Innate Immunity 4: 105-114 [Abstract]  
• Abrahamson, S. L., Wu, H.-M., Williams, R. E., Der, K., Ottah, N., Little, R., Gazzano-Santoro, H., Theofan, G., Bauer, R., Leigh, S., Orme, A., Horwitz, A. H., Carroll, S. F., Dedrick, R. L. (1997). Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/ Permeability-increasing Protein. IMPLICATIONS IN BIOLOGICAL ACTIVITY. J. Biol. Chem. 272: 2149-2155 [Abstract] [Full Text]  
• Burnett, R.J., Lyden, C.A., Tindal, C.J., Marra, M.N., Neely, A.N., Solomkin, J.S. (1995). Effects of bactericidal/permeability-increasing protein upon mononuclear cell interactions with endotoxin: evidence for cell binding. Innate Immunity 2: 349-357 [Abstract]  
• Famularo, G., De Simone, C., Arrigoni Martelli, E., Jirillo, E. (1995). Carnitine and septic shock: a review. Innate Immunity 2: 141-147 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS